| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8444119 | European Journal of Cancer | 2013 | 10 Pages |
Abstract
Patients with adipocytic sarcoma may benefit from treatment with cixutumumab. Cixutumumab treatment was well tolerated, with limited gastrointestinal AEs, fatigue and hyperglycaemia.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
P. Schöffski, D. Adkins, J.-Y. Blay, T. Gil, A.D. Elias, P. Rutkowski, G.K. Pennock, H. Youssoufian, H. Gelderblom, R. Willey, D.O. Grebennik,